Orthopediatrics Corp (NASDAQ:KIDS) – Analysts at Piper Jaffray Companies dropped their Q3 2019 earnings per share estimates for shares of Orthopediatrics in a research note issued to investors on Thursday, August 8th. Piper Jaffray Companies analyst M. O’brien now forecasts that the company will post earnings per share of ($0.13) for the quarter, down from their prior estimate of ($0.06). Piper Jaffray Companies also issued estimates for Orthopediatrics’ Q4 2019 earnings at ($0.18) EPS, Q1 2020 earnings at ($0.22) EPS, Q2 2020 earnings at ($0.12) EPS, Q3 2020 earnings at ($0.09) EPS, Q4 2020 earnings at ($0.12) EPS and FY2020 earnings at ($0.55) EPS.
A number of other analysts have also recently commented on KIDS. BidaskClub raised shares of Orthopediatrics from a “sell” rating to a “hold” rating in a report on Friday, August 2nd. Zacks Investment Research cut shares of Orthopediatrics from a “buy” rating to a “hold” rating in a report on Tuesday. Needham & Company LLC assumed coverage on shares of Orthopediatrics in a report on Wednesday, June 19th. They set a “buy” rating and a $53.00 target price for the company. BTIG Research reissued a “buy” rating and issued a $44.00 price objective on shares of Orthopediatrics in a research note on Friday, May 10th. Finally, ValuEngine cut shares of Orthopediatrics from a “buy” rating to a “hold” rating in a research note on Thursday, August 1st. Three equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Orthopediatrics presently has a consensus rating of “Buy” and an average price target of $44.25.
Orthopediatrics (NASDAQ:KIDS) last announced its earnings results on Wednesday, August 7th. The company reported ($0.14) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.09) by ($0.05). Orthopediatrics had a negative net margin of 15.77% and a negative return on equity of 13.90%. The business had revenue of $18.20 million for the quarter, compared to analysts’ expectations of $18.44 million. During the same period in the prior year, the company posted ($0.21) earnings per share. The firm’s quarterly revenue was up 20.5% on a year-over-year basis.
Several hedge funds and other institutional investors have recently made changes to their positions in KIDS. Aperio Group LLC purchased a new stake in shares of Orthopediatrics in the second quarter worth $39,000. BNP Paribas Arbitrage SA increased its stake in shares of Orthopediatrics by 83,150.0% in the first quarter. BNP Paribas Arbitrage SA now owns 1,665 shares of the company’s stock worth $74,000 after purchasing an additional 1,663 shares in the last quarter. Meadow Creek Investment Management LLC increased its stake in shares of Orthopediatrics by 125.0% in the second quarter. Meadow Creek Investment Management LLC now owns 2,160 shares of the company’s stock worth $84,000 after purchasing an additional 1,200 shares in the last quarter. Metropolitan Life Insurance Co. NY purchased a new stake in shares of Orthopediatrics in the fourth quarter worth $93,000. Finally, Bank of Montreal Can boosted its position in shares of Orthopediatrics by 56.3% during the second quarter. Bank of Montreal Can now owns 2,853 shares of the company’s stock worth $112,000 after acquiring an additional 1,028 shares during the last quarter. 49.45% of the stock is owned by hedge funds and other institutional investors.
Orthopediatrics Company Profile
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company's products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail products, PediLoc tibia products, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, RESPONSE Spine systems, Bandloc, and Pediguard.
Featured Story: After-Hours Trading
Receive News & Ratings for Orthopediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthopediatrics and related companies with MarketBeat.com's FREE daily email newsletter.